Curative Effect of Heat-sensitive Moxibustion on Primary Dysmenorrhea: A Meta-Analysis

Table 1

The basic characteristics of the included studies. T: trial group; C: control group; NA: not reported; ①Total effective rate; ②VAS score; ③Symptom score; and ④CMSS score.

Trail	Sample Size (T/C)	Age (y), Mean ± SD or Median (Range)		Duration		T	C	Main Outcomes	Follow-up time/month
		T	C	T	C
Guan, 2021	47/46	20.73 ± 5.46	21.41 ± 5.92	5.43 ± 1.22m	5.19 ± 1.38m	HSM	Traditional Chinese medicine	①④	—
Lin, 2021	30/31	23.70 ± 2.78	24.03 ± 2.63	7.60 ± 2.58	8.48 ± 2.57	HSM	Sustained-Release ibuprofen capsules	①②③	3
Zhang, 2020	32/32	18.56 ± 2.35	17.22 ± 3.39	12.46 ± 4.35 m	11.96 ± 4.25m	HSM	Moxibustion	①②④	3
Li, 2020	30/30	23.5	25.1	22.8	4.6	HSM	Sustained-Release ibuprofen capsules	①②	—
Zhu, 2020	31/31	22.97 ± 4.04	21.97 ± 3.63	4.26 ± 2.68	3.09 ± 2.63	HSM	Traditional Chinese medicine	①	3
Wang, 2020	30/30	24.57 ± 3.88	23.73 ± 2.92	7.27 ± 3.86	6.90 ± 3.62	HSM	Traditional Chinese medicine	①②	3
Han, 2019	30/30	NA	NA	NA	NA	HSM	Traditional Chinese medicine	①②③	—
Wang, 2019	30/30	24.4	24.4	4m-13 y	4m-13y	HSM	Traditional Chinese medicine	①②	3
Li, 2019	40/40	22.93 ± 3.41	22.65 ± 3.27	9.43 ± 3.59m	9.06 ± 3.62m	HSM	Progesterone	①④	1
Ou, 2017	30/30	NA	NA	NA	NA	HSM	Moxibustion	①	—
Ma, 2016	35/35	30.0 ± 4.5	30.2 ± 5.0	2.5 ± 0.5	3.0 ± 0.5	HSM	Sustained-Release ibuprofen capsules	①	—
Xie, 2016	40/40	19.3 ± 1.2	19.2 ± 1.3	10.7 ± 2.3 m	10.9 ± 2.5m	HSM	Moxibustion	①	—
Lu, 2015	40/40	14-30	15-29	8m-7 y	6m-6.5y	HSM	Sustained-Release ibuprofen capsules	①②	—
Zhang, 2014	61/56	22.76 ± 4.26	23.30 ± 4.51	6.76 ± 2.26	7.03 ± 2.71	HSM	Moxibustion	②④	3
Zhong, 2014	30/30	23.774 ± 2.582	22.900 ± 2.537	6.67 ± 2.264	7.000 ± 1.894	HSM	Moxibustion	①②③	3
Li, 2013	20/20	20-42	20-42	1-5y	1-5y	HSM	Moxibustion	①	—
Nie, 2010	47/46	19.25 ± 4.03	19.24 ± 3.76	3.02 ± 1.38	2.93 ± 1.27	HSM	Acupuncture	①③	—
Rao, 2009	30/30	22.07 ± 4.50	21.47 ± 4.8	3.65 ± 2.75	3.51 ± 2.99	HSM	Sustained-Release ibuprofen capsules	①③	—
Zhang, 2008	33/32	NA	NA	NA	NA	HSM	Moxibustion	①③	—